Treatment of Resectable Submandibular Gland Cancer with High-Grade Histology or Extraglandular Tumour Extension — Clinically Node-Negative Neck (cN0)

Clinical scenario

This protocol addresses patients with resectable submandibular gland cancer who present with a clinically node-negative neck (cN0) but carry either high-grade histology or extraglandular tumour extension — features that place them at elevated risk and shape the management plan.

Why neck management is central in this setting

Even with a negative clinical neck examination, high-grade submandibular gland malignancies carry a substantial prevalence of occult cervical lymph node involvement — exceeding that seen in parotid malignancies. Elective neck management is therefore a standard component of the surgical strategy, planned on the basis of cytological and radiological findings.

Treatment approach — overview

The primary intervention is surgical resection incorporated into a structured neck dissection. Post-operative radiotherapy is a potential component of the plan, with whether it is applied — and how — depending on specific pathological and margin-related criteria outlined in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.esmoop.2022.100602

In case of high-grade malignancy without clinical evidence of cervical lymph node involvement, selective neck dissection involving level I, II and III lymph nodes is standard procedure as the prevalence of cervical lymph node metastasis in submandibular gland malignancies is high, exceeding that of the parotid malignancies.

Elective neck dissection (END) for submandibular gland malignancies should be planned based on cytological and radiological findings.

Post-operative local RT is recommended for T3-T4 and intermediate/high-grade tumours and in cases with close resection margins (1-5 mm; 30 x 2 Gy), incomplete resection margins (33 x 2 Gy) or perineural growth [IV, A].

View source ↗